XML 21 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Class 1 Common Stock
Class 2 Common Stock
Previously Reported
Revision of Prior Period, Adjustment
Common Stock
Class 1 Common Stock
Common Stock
Class 2 Common Stock
Common Stock
Previously Reported
Class 1 Common Stock
Common Stock
Previously Reported
Class 2 Common Stock
Common Stock
Revision of Prior Period, Adjustment
Class 1 Common Stock
Common Stock
Revision of Prior Period, Adjustment
Class 2 Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Previously Reported
Additional Paid-in Capital
Revision of Prior Period, Adjustment
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Previously Reported
Accumulated Deficit
Revision of Prior Period, Adjustment
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Previously Reported
Beginning balance (shares) at Dec. 31, 2018 0       68,383,000 (68,383,000)                              
Beginning balance at Dec. 31, 2018 $ 0       $ 141,676 $ (141,676)                              
Ending balance (shares) at Dec. 31, 2019 0                                        
Ending balance at Dec. 31, 2019 $ 0                                        
Beginning balance (shares) at Dec. 31, 2018             89,953,000 8,197,000 29,767,000 0 60,186,000 8,197,000                  
Beginning balance at Dec. 31, 2018 34,120 $ 1,908     $ (107,556) $ 141,676 $ 9 $ 1 $ 5 $ 0 $ 4 $ 1 $ 141,065 $ 8,692 $ 132,373 $ (106,955) $ 1,908 $ (116,253) $ 9,298 $ 0 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Stock-based compensation expense 2,114                       2,114                
Issuance of common stock under stock plans (shares)             1,467,000                            
Issuance of common stock under stock plans 1,127                       1,127                
Foreign currency translation 0                                        
Net loss (22,803)                             (22,803)          
Ending balance (shares) at Dec. 31, 2019             91,420,000 8,197,000                          
Ending balance at Dec. 31, 2019 $ 16,466           $ 9 $ 1         144,306     (127,850)       0  
Ending balance (shares) at Dec. 31, 2020 0                                        
Ending balance at Dec. 31, 2020 $ 0                                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Stock-based compensation expense 3,063                       3,063                
Issuance of common stock under stock plans (shares)             1,340,000                            
Issuance of common stock under stock plans 1,308                       1,308                
Foreign currency translation 0                                        
Net loss (17,027)                             (17,027)          
Ending balance (shares) at Dec. 31, 2020     92,760,000 8,197,000     92,760,000 8,197,000                          
Ending balance at Dec. 31, 2020 $ 3,810           $ 9 $ 1         148,677     (144,877)       0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-02 [Member]                                        
Ending balance (shares) at Dec. 31, 2021 0                                        
Ending balance at Dec. 31, 2021 $ 0                                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Reverse recapitalization and PIPE Financing (shares)             44,522,000 (1,659,000)                          
Reverse recapitalization and PIPE financing 329,886           $ 5           329,881                
Fair value of Earnout Shares (230,995)                       (230,995)                
Issuance and vesting of Earnout Shares (shares)             10,204,000 713,000                          
Issuance and vesting of Earnout Shares 237,009           $ 1           237,008                
Stock-based compensation expense 26,151                       26,151                
Issuance of common stock under stock plans (shares)             4,323,000                            
Issuance of common stock under stock plans 6,227                       6,227                
Shares issued for exercise of warrants (shares)             3,000                            
Shares issued for exercise of warrants 38                       38                
Shares exchanged in connection with Secondary Offering (shares)             2,028,000 (2,028,000)                          
Warrant Exchange (shares)             3,746,000                            
Exchange of shares (shares)             1,827,000 (1,827,000)                          
Foreign currency translation (1,292)                                     (1,292)  
Net loss (61,200)                             (61,200)          
Ending balance (shares) at Dec. 31, 2021     159,413,000 3,396,000     159,413,000 3,396,000                          
Ending balance at Dec. 31, 2021 $ 309,634           $ 15 $ 1         $ 516,987     $ (206,077)       $ (1,292)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Reverse recapitalization and PIPE Financing (shares) 41,492,000                                        
Shares exchanged in connection with Secondary Offering (shares) 20,000,000                                        
Ending balance (shares) at Jan. 12, 2021 145,266,000   138,728,373 6,537,735